Quick Reference: Treating Patients With Advanced HCC

From Clinical Care Options (CCO), watch video featuring expert perspectives on the use of immunotherapy for HCC

Lipika Goyal, MD Amit G. Singal, MD, MS Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: November 24, 2020 Expired: November 23, 2021

Overview of HCC and Key Considerations for Systemic Therapy

Immune Checkpoint Inhibitors in Contemporary Management of Advanced HCC

Practical Guidance for Using Immune Checkpoint Inhibitors

In slides from Clinical Care Options (CCO), experts provide insights on the optimal treatment of advanced HCC

Mark Yarchoan, MD Released: November 19, 2020

Review an expert commentary from Clinical Care Options (CCO) on choosing treatment for patients with HCC and Child-Pugh B cirrhosis

Mark Yarchoan, MD Released: November 18, 2020

Video of expert discussion on assessing HER2 status and using HER2-targeted agents for gastrointestinal cancers, from Clinical Care Options (CCO)

Mark D. Pegram, MD
Program Director Michael F. Press, MD, PhD
Program Director Axel Grothey, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ ABIM MOC: maximum of 0.75 Medical Knowledge MOC point(s) ABPath MOC: maximum of 0.75 Lifelong Learning (Part II) and Self-Assessment Module (SAM) point(s) Released: November 2, 2020 Expired: November 1, 2021

Assessment of HER2 Status in Gastrointestinal Cancers (24 minutes)

Current Best Practices and Novel Approaches in the Use of HER2-targeted Agents in Metastatic GI Cancers (27 minutes)